National Instrument 41-101 General Prospectus Requirements, B.C. Reg. 59/2008

Section 13.7

Marketing materials during the waiting period

Cite as National Instrument 41-101 General Prospectus Requirements, B.C. Reg. 59/2008, s. 13.7 · last amended September 19, 2025 · read from BC Laws on November 17, 2026

The text

(1) An investment dealer that provides marketing materials to a potential investor during the waiting period is exempt from the prospectus requirement with respect to providing the marketing materials if (a) the marketing materials comply with subsections (2) to (8); (b) other than contact information for the investment dealer or underwriters and any comparables, all information in the marketing materials concerning the issuer, the securities or the offering is disclosed in, or derived from, the preliminary prospectus or any amendment; (c) other than prescribed language, the marketing materials contain the same cautionary language in bold type as contained on the cover page, and in the summary, of the preliminary prospectus; (d) a template version of the marketing materials is approved in writing by the issuer and the lead underwriter before the marketing materials are provided; (e) a template version of the marketing materials is filed on or before the day that the marketing materials are first provided; (f) a receipt for the preliminary prospectus has been issued in the local jurisdiction; and (g) the investment dealer (i) includes, in the marketing materials, a statement that the preliminary prospectus and any amendment are accessible through SEDAR+, or (ii) provides, with the marketing materials, a copy of the preliminary prospectus and any amendment. (2) If a template version of the marketing materials is approved in writing by the issuer and lead underwriter under paragraph (1) (d) and filed under paragraph (1) (e), an investment dealer may provide a limited-use version of the marketing materials that (a) has a date that is different than the template version; (b) contains a cover page referring to the investment dealer or underwriters or a particular investor or group of investors; (c) contains contact information for the investment dealer or underwriters; or (d) has text in a format, including the type's font, colour or size, that is different than the template version. (3) If a template version of the marketing materials is divided into separate sections for separate subjects and is approved in writing by the issuer and lead underwriter under paragraph (1) (d), and that template version is filed under paragraph (1) (e), an investment dealer may provide a limited-use version of the marketing materials that includes only one or more of those separate sections. (4) The issuer may remove any comparables, and any disclosure relating to those comparables, from the template version of the marketing materials before filing it under paragraph (1) (e) or (7) (a) if (a) the comparables, and any disclosure relating to the comparables, are in a separate section of the template version of the marketing materials; (b) the template version of the marketing materials that is filed contains a note advising that the comparables, and any disclosure relating to the comparables, were removed in accordance with this subsection, provided that the note appears immediately after where the removed comparables and related disclosure would have been; (c) if the prospectus is filed in the local jurisdiction, a complete template version of the marketing materials containing the comparables, and any disclosure relating to the comparables, is delivered to the securities regulatory authority; and (d) the complete template version of the marketing materials contains disclosure proximate to the comparables which (i) explains what comparables are; (ii) explains the basis on which the other issuers were included in the comparables and why the other issuers are considered to be an appropriate basis for comparison with the issuer; (iii) explains the basis on which the compared attributes were included; (iv) states that the information about the other issuers was obtained from public sources and has not been verified by the issuer or the underwriters; (v) discloses any risks relating to the comparables, including risks in making an investment decision based on the comparables; and (vi) states that if the comparables contain a misrepresentation, the investor does not have a remedy under securities legislation. (5) Marketing materials provided under subsection (1) must be dated and include the following legend, or words to the same effect, on the first page: A preliminary prospectus containing important information relating to the securities described in this document has been filed with the securities regulatory authorit[y/ies] in [each of/certain of the provinces/provinces and territories of Canada] and is accessible through SEDAR+. Copies of the preliminary prospectus and any amendment may be obtained from [insert contact information for dealer or other relevant person or entity.]. The preliminary prospectus is still subject to completion. There will not be any sale or any acceptance of an offer to buy the securities until a receipt for the final prospectus has been issued. This document does not provide full disclosure of all material facts relating to the securities offered. Investors should read the preliminary prospectus, the final prospectus and any amendment for disclosure of those facts, especially risk factors relating to the securities offered, before making an investment decision. (6) If marketing materials are provided during the waiting period under subsection (1), the issuer must include the template version of the marketing materials filed under paragraph (1) (e) in its final prospectus, or incorporate by reference the template version of the marketing materials filed under paragraph (1) (e) into its final prospectus, in the manner described in subsection 36A.1 (1) of Form 41-101F1 or subsection 11.6 (1) of Form 44-101F1, as applicable. (7) If the final prospectus or any amendment modifies a statement of a material fact that appeared in marketing materials provided during the waiting period under subsection (1), the issuer must (a) prepare and file, at the time the issuer files the final prospectus or any amendment, a revised template version of the marketing materials that is blacklined to show the modified statement, and (b) include in the final prospectus, or any amendment, the disclosure required by subsection 36A.1 (3) of Form 41-101F1 or subsection 11.6 (3) of Form 44-101F1, as applicable. (8) A revised template version of the marketing materials filed under subsection (7) must comply with section 13.8. (9) If marketing materials are provided during the waiting period under subsection (1) but the issuer does not comply with subsection (6), the marketing materials are deemed for purposes of securities legislation to be incorporated into the issuer's final prospectus as of the date of the final prospectus to the extent not otherwise expressly modified or superseded by a statement contained in the final prospectus.
Read the National Instrument 41-101 General Prospectus Requirements on BC Laws ↗

Made under Securities Act, RSBC 1996, c. 418.